Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Abbott finally settles a consent decree with the FDA over problems with its diagnostics manufacturing operation, a dozen years after the watchdog agency issued the fiat.
An unsealed whistleblower lawsuit accuses Medtronic of violating the Medicare False Claims Act through illegal marketing of its Infuse bone growth protein, alleging that the medical device maker installed a crony as editor of an influential spine journal to push positive data on the controversial compound.
An FDA advisory panel says riskier medical devices for treating obesity should deliver more weight loss than less-risky treatments to justify the federal watchdog agency’s approval.